A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...
Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...
A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
A Vancouver woman and her husband filed a lawsuit against Legacy Salmon Creek Medical Center and her physician over surgery complications. DeAndras and Ryan Macheras filed the complaint Dec. 11 in ...
If you’re a pet parent you know it’s not always easy to bring your furry friend to the vet for care. Now, there’s a new ...
The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.
For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...
In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...
Introduction Each year, millions of people experience recurrent diverticulitis episodes. Elective sigmoid colon resection reduces the risk of recurrence, but The American Society of Colon and Rectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback